AstraZeneca’s BioVentureHub CEO Magnus Björsne tells Mike Ward, global director of content for Informa Pharma Intelligence's insights portfolio, about the exchange's intention to generate a climate of open innovation to help grow and nurture the Scandinavian life science ecosystem. AZ BioVentureHub was established in 2014 in Gothenberg, Sweden, aimed at emerging biotech and medtech businesses and academic groups and already has attracted 18 companies, one academic group, four external sponsors and two scientific partners.
Want to elevate your brand and connect with potential partners? The Cell & Gene Exchange brings together leaders from patient advocacy groups, industry, academia and government to network, exchange ideas and explore partnership opportunities. Learn more here.